- Breastfeeding Chariz Solomon Wears Hair Tie On Wrist For Breastfeeding. Here's Why
- Toddler Let Your Toddlers Learn How to Entertain Themselves!
- Baby 'Hope, Faith, And Love' Ang Hiling Ni Romnick Sarmenta Para Sa Kanyang Baby
- Toddler The Best Investment: Set Aside Time For These 5 Things To Raise Great Kids
WHO Reverses Statement On Ibuprofen For COVID-19: No Reports On Negative EffectsAn earlier statement discourages the use of the NSAID for symptoms of COVIDby Lei Dimarucut-Sison .
The World Health Organization (WHO) today retracted its earlier recommendation not to use ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) commonly used for pain and fever, in managing the symptoms of COVID-19 when self-medicating.
On Tuesday, WHO spokesman Christian Lindmeier was asked by reporters about a study published in the medical journal The Lancet that says NSAIDs boost an enzyme that could facilitate and worsen COVID-19 infections. He replied that the WHO is "looking into this to give further guidance."
"In the meantime, we recommend using rather paracetamol, and do not use ibuprofen as a self-medication. That's important," he added.
However, if ibuprofen is "prescribed by the healthcare professionals, then, of course, that's up to them."
Today, though, the agency clarified in a statement that "At present, based on currently available information, WHO does not recommend against the use of ibuprofen."
"We are also consulting with physicians treating COVID-19 patients and are not aware of reports of any negative effects of ibuprofen, beyond the usual known side effects that limit its use in certain populations."ADVERTISEMENT - CONTINUE READING BELOWCONTINUE READING BELOWRecommended Videos
COVID-19 symptoms include cough, shortness of breath, and fever. Ibuprofen, which is available over-the-counter, is commonly used to manage fever and pain.
Among the known side effects of ibuprofen are stomach or intestinal bleeding. It also has contraindications for those with heart disease, asthma, liver or kidney disease, and those who have a history of stroke or blood clots.ADVERTISEMENT - CONTINUE READING BELOW
Nonetheless, for its specific use in COVID-19 cases, WHO said it is not aware of published clinical- or population-based data on the topic.
Trending in Summit Network